GlaxoSmithKline VP of Finance Salaries in Hagerstown, MD | Comparably
"GlaxoSmithKline discovers, develops and manufactures pharmaceuticals, vaccines and consumer healthcare products." read more
EMPLOYEE
PARTICIPANTS
39
TOTAL
RATINGS
383

GlaxoSmithKline VP of Finance Salaries in Hagerstown, MD

The average GlaxoSmithKline VP of Finance in Hagerstown, MD earns an estimated $150,655 annually. GlaxoSmithKline's VP of Finance compensation is $55,875 less than the US average for a VP of Finance.

In Hagerstown, MD, The Finance Department at GlaxoSmithKline earns $16,280 more on average than the Customer Support Department.

Last updated 2 years ago.

$50k
$90k
$145k
$200k
$309k
$430k
$518k
$150,655
Average Compensation
$150,655
avg. base

VP of Finance Salaries at GlaxoSmithKline

In Hagerstown, MD, VPs of Finance earn $32,747 more than Accounting Managers.

Accounting Manager
$118k*
Senior Accountant
$94k*
Financial Analyst
$89k*
Accountant
$69k*
Business Analyst
$60k*
* estimated salary

Compensation at GlaxoSmithKline by Department

In Hagerstown, MD, The Finance Department averages $16,280 more than the Customer Support Department, and $15,728 less than the Sales Department

Sales
$97,661 Avg. total comp.
+$16k
Finance
$81,933 Avg. total comp.
Customer Support
$65,653 Avg. total comp.
-$16k

VP of Finance Compensation by Gender (All Companies)

The average female VP of Finance at companies similar size to GlaxoSmithKline reported making $188,034, while the average male VP of Finance at similar sized companies reported making $216,094.

VP of Finance Compensation by Ethnicity (All Companies)

The average Caucasian VP of Finance at companies similar size to GlaxoSmithKline reported making $207,596, while the average Hispanic or Latino VP of Finance at similar sized companies reported making $170,500.

How VPs of Finance at GlaxoSmithKline Rate Their Compensation

The majority of VPs of Finance at GlaxoSmithKline believe they're compensated fairly. 100% of VPs of Finance at GlaxoSmithKline say they receive annual bonuses, and the majority (54%) are satisfied with their benefits. See more compensation ratings at GlaxoSmithKline

×
Rate your company